Comparison between using PMMA and AN69ST membrane hemofilter in Continuous hemodiafiltration (CPAC study)
Not Applicable
- Conditions
- burn, severe acute pancreatitis, sepsis
- Registration Number
- JPRN-UMIN000028025
- Lead Sponsor
- Saga University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
-Pregnant women -Patients with chronic kidney disease or who received RRT before randomization -Patients with terminal cancer -Patients with body weight less than 30 kg -Patients considered ineligible for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Changes of scores (SOFA, SAPS2, APACHE2, DIC score, CAI) at 48 and 72 hours after enrollment
- Secondary Outcome Measures
Name Time Method -Duration of mechanical ventilation in 28 days -Survival rate at 90 days -ICU stay days -Hospital stay days -Changes of plasma lactate and IL-6 level at 72 hours after continuous hemodiafiltration -Filter lifetime -Total fluid volume